American College of Cardiology and Medscape
- From Prevention to Prognosis: AI's Role in Heart Failure
- Heart Failure in Women: Key Differences and Clinical Tips
- Targeting Obesity to Improve HFpEF Outcomes
- HDL-C Levels' Role in Cardioprotection: 5 Things to Know
- How Low Should You Go? Is Very Low LDL-C Safe?
- Diagnosing Cardiac Amyloidosis: 5 Things to Know
- Managing Dyslipidemia in 50-Year-Old Man With Hypothyroidism
- The Ever-Evolving Landscape of Lipid-Lowering Therapies
- Surveilling Heart Rejection: A Guide to Noninvasive Methods
- Upping the Pace in Acute Decompensated Heart Failure Therapy
- Key Steps to Optimizing GDMT in Heart Failure
- Best Practices for SGLT2 Inhibitors in HFpEF Treatment
- Measuring Atherogenic Lipids: Does One Equation Rise Above?
- Key Takeaways From the AHA Statement on CAM in HF
- Targeted Strategies in Lipid-Lowering Therapy
- Practical Tips for Heart Failure Prevention
- What About Lp(a)? To Test or Not to Test
- CRT in HFrEF Management: Updates Plus 'What's Next?'
- Heart Transplantation Outcomes After the New OPTN Policy
- State of the Art in NAFLD/NASH Identification and Management